Elevated inflammatory type 2 biomarkers at baseline predict multicomponent clinical remission following dupilumab treatment in patients with moderate-to-severe asthma
Titel:
Elevated inflammatory type 2 biomarkers at baseline predict multicomponent clinical remission following dupilumab treatment in patients with moderate-to-severe asthma
Auteur:
Llano, L.A. Pérez De Guilleminault, L. Canonica, G.W. Pavord, I.D. Couillard, S. Porsbjerg, C. Brusselle, G. Castro, M. Bourdin, A. Altincatal, A. Kwah, J.H. Ledanois, O.